Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.

Lethality of Alzheimer Disease and Its Impact on Nursing Home Placement

Arrighi, Henry Michael, Neumann, Peter J., Lieberburg, Ivan M., Townsend, Raymond J. · 2010 · Alzheimer Disease & Associated Disorders

Abstract

This analysis evaluates the progression of Alzheimer disease (AD) severity and compares the life expectancy and nursing home placement rates for AD patients with the same measures in the general population. Data from the Consortium to Establish a Registry for Alzheimer Disease were analyzed to estimate expected survival, time spent in each Clinical Dementia Rating stage, and nursing home admission rate for a hypothetical cohort of patients aged 70 years with new-onset AD. Corresponding estimates for the US general population were calculated from the 2004 National Nursing Home Survey and the 2003 life table estimates from the US Census Bureau. Deaths from all causes by age 80 years are expected in 61% of AD patients and in 30% of the general population. From the age of 70 to 80 years, a typical AD patient spends 4 years at Clinical Dementia Rating stage 3 (severe), 3 years at stage 2 (moderate), and 3 years at stage 1 (mild). Nursing home admission by the age of 80 years is expected for approximately 75% of surviving AD patients, but for only 4% of the general population. Among persons aged > or =65 years, reported age-adjusted and sex-adjusted mortality rates for AD increased to 33% from 1999 to 2004.

Overview

Integrity signals

Registry

Crossref · 10.1097/wad.0b013e31819fe7d1

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 36 references

Cited by

See all 130

Metadata

Authors
Arrighi, H. M., Neumann, P. J., Lieberburg, I. M., & Townsend, R. J.
Affiliations
  • Elan Pharmaceuticals, Inc. (Ireland) (IE)
  • Tufts Medical Center (US)
  • University of California, San Francisco (US)
Corresponding author
  • Arrighi, Henry Michael
  • Lieberburg, Ivan M.
  • Townsend, Raymond J.
Venue
Alzheimer Disease & Associated Disorders
Published
2010-01
Volume
24
Issue
1
Pages
90-95
ISSN
0893-0341 (ISSN-L)
OpenAlex
W2094938161
Cited by
126
References
36
Citations by year
2026: 4 · 2025: 5 · 2024: 9 · 2023: 10 · 2022: 14 · 2021: 11 · 2020: 6 · 2019: 6 · 2018: 8 · 2017: 7 · 2016: 7 · 2015: 14 · 2014: 11 · 2013: 6 · 2012: 4
FWCI
2.84
Type
journal article
Language
en
Open access
closed
Locations
  • Alzheimer Disease & Associated Disorders (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Geriatrics and Gerontology › Geriatric Care and Nursing Homes
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
Alzheimer's disease, mortality, nursing home admission, life expectancy, Clinical Dementia Rating, disease progression, survival estimates, mortality trends, older adults
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Female, Homes for the Aged, Humans, Life Expectancy, Male, Nursing Homes, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lethality of Alzheimer Disease and Its Impact on Nursing Home Placement. https://app.cochat.ai/papers/10.1097/wad.0b013e31819fe7d1
The paper
Arrighi, H. M., Neumann, P. J., Lieberburg, I. M., & Townsend, R. J. (2010). Lethality of Alzheimer Disease and Its Impact on Nursing Home Placement. Alzheimer Disease & Associated Disorders. https://doi.org/10.1097/wad.0b013e31819fe7d1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.